COMMUNIQUÉS West-GlobeNewswire

Ovid Therapeutics Announces Two Oral Presentations at the 14th Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV)
09/05/2018
New preclinical data provide further evidence of TAK-935/OV935’s novel mechanism of action, as a potential treatment for rare developmental and epileptic encephaolopathies (dEE) First presentation of preclinical data on [...]
ProQR Announces Results for the First Quarter of 2018
09/05/2018
Key updates Eight out of twelve patients have been enrolled in a Phase 1/2 clinical trial of QR-110 in adults and children with LCA 10. Interim data are expected in the second half of 2018, with full data expected [...]
Neos Therapeutics Reports First Quarter 2018 Financial Results
09/05/2018
Company to Host Conference Call at 8:30am ET Today DALLAS and FORT WORTH, Texas, May 09, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS ), a pharmaceutical company focused on developing, manufacturing [...]
Idera Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update
09/05/2018
EXTON, Pa., May 09, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ: IDRA ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel nucleic [...]
Pain Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update on REMOXY® ER
09/05/2018
– June 26 th Advisory Committee Meeting for REMOXY ER – – August 7 th PDUFA Target Date for REMOXY ER – AUSTIN, Texas, May 09, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE ), a drug development company [...]
Kamada to Announce First Quarter 2018 Financial Results and Host Conference Call on May 15
09/05/2018
REHOVOT, Israel, May 09, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA ) (TASE: KMDA ), a plasma-derived protein therapeutics company, today announced that it will release financial results for the quarter ended [...]
Surgery Partners, Inc. Announces First Quarter 2018 Results
09/05/2018
Quarterly Highlights Reflect Significant Strategic Progress; Affirms Full Year Expectations BRENTWOOD, Tenn., May 09, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY ) ("Surgery Partners" or the "Company [...]
R1 RCM Reports First Quarter 2018 Results
09/05/2018
CHICAGO, May 09, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced results for the three months [...]
Protalix BioTherapeutics Reports 2018 First Quarter Results and Provides Corporate Update
09/05/2018
CARMIEL, Israel, May 09, 2018 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE: PLX ), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic [...]
PotNetwork Holdings, Inc. Releases 2018 Investor Relations FAQ
09/05/2018
U.S. Domestic and International Sales Strategy, Brand Positioning and Business Development Commitments to Shareholders FORT LAUDERDALE, Fla., May 09, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- PotNetwork Holdings, Inc [...]
Capital Senior Living Corporation to Present at the Bank of America Merrill Lynch 2018 Health Care Conference on Wednesday, May 16, 2018
09/05/2018
DALLAS, May 09, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE: CSU ), one of the nation’s largest operators of senior living communities, today announced that management will make a [...]
RadNet Reports First Quarter Financial Results
09/05/2018
Severe weather in the Northeast impacted Total Net Revenue (“Revenue”) by an estimated $5.9 million and Adjusted EBITDA (1) by $5.8 million in the first quarter, significantly decreasing profitability Despite same [...]
Invivoscribe Announces a Regional “Center of Excellence” Reference Laboratory in Beirut to Offer Specialized Gene Panels
09/05/2018
SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) -- Invivoscribe Technologies Inc., a global precision diagnostics company in oncology and personalized molecular medicine, announces a partnership with the American University of [...]
Infant Bacterial Therapeutics AB Nomination Committee modifies its proposal to the Board of Directors
09/05/2018
The IBT Nomination Committee presented its proposals to the AGM in April 2018, which will be held on May 15, 2018. The Nomination Committee has subsequently been informed that Nasdaq Stockholm, within the framework of [...]
Vistin Pharma ASA : Share capital increase registered
09/05/2018
Oslo, Norway, 9 May 2018 Vistin Pharma ASA (OSE: VISTIN), reference is made to the Company's announcements on 8 May regarding the approval by the annual general meeting of the Private Placement of 26,785,715 shares at a [...]
Trading in Novo Nordisk shares by board members, executives and associated persons on 8 May 2018
09/05/2018
Bagsværd, Denmark, 9 May 2018 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of [...]
Trading by management and close relations of management
09/05/2018
Read the full announcement in the attached file Attachment 2018_29_Trading_by_management_EN
Nexstim Plc launches NBT® system for depression at the US Clinical TMS Society Annual Meeting in New York
09/05/2018
Press release, Helsinki, 9 May 2018, at 12 noon NBT ® system is the only FDA approved personalised navigation approach for accurate targeted brain stimulation in therapy Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or [...]
Cytovance® Biologics Successfully Completes FDA Inspection
09/05/2018
OKLAHOMA CITY, May 09, 2018 (GLOBE NEWSWIRE) -- Cytovance® Biologics, Inc., a leading full-service biopharmaceutical contract development and manufacturing services company is pleased to announce the United States Food [...]

Pages